1999
DOI: 10.1016/s0002-9270(99)00151-3
|View full text |Cite
|
Sign up to set email alerts
|

Primary advanced gastric small cell carcinoma A case report and review of the literature

Abstract: We report a 73-yr-old man with primary advanced gastric small cell carcinoma, pure type. A large, Borrman type I tumor was located from the cardia to the entire gastric fundus and upper body. Atypical cells showed a round nucleus, small nucleolus, dense to granular chromatin, and scant cytoplasm. The histological findings indicates an advanced stage and exposure to the gastric serosa. Mitotic figures were observed. There was a proliferation of a sheet-like, solid pattern, but no rosette-like, sqamoid, or gland… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
11
0

Year Published

2002
2002
2013
2013

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 11 publications
2
11
0
Order By: Relevance
“…Regardless of the local modality of therapy (surgery or radiotherapy), the addition of systemic chemotherapy improves outcomes and survival, and therefore chemotherapy should be given whenever possible. Several studies have reported rapid systemic recurrence and an unfavourable outcome with local therapy alone for scc of other sites 20,[29][30][31] . In the present study of gu scc, we found that, compared with patients treated with surgery or radiotherapy alone, patients who received systemic therapy showed a trend toward better survival (12.3 months vs. 6.9 months, p = 0.22) regardless of the primary location, site, and stage of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…Regardless of the local modality of therapy (surgery or radiotherapy), the addition of systemic chemotherapy improves outcomes and survival, and therefore chemotherapy should be given whenever possible. Several studies have reported rapid systemic recurrence and an unfavourable outcome with local therapy alone for scc of other sites 20,[29][30][31] . In the present study of gu scc, we found that, compared with patients treated with surgery or radiotherapy alone, patients who received systemic therapy showed a trend toward better survival (12.3 months vs. 6.9 months, p = 0.22) regardless of the primary location, site, and stage of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…The initial clinical manifestations of GSCCs are often due to loco-regional disease and thus are indistinguishable from other histologic types arising from the same site. Symptoms can be due to the presence of a mass, ulceration, and bleeding, invasion of adjacent structures, or systemic manifestations of malignancy [1, 5, 8]. GSCC can present with paraneoplastic syndromes, as occurs with small-cell lung cancer (SCLC), and secrete ectopic hormones, such as parathyroid hormone, antidiuretic hormone, calcitonin, or serotonin.…”
Section: Discussionmentioning
confidence: 99%
“…Microscopically, small cell gastric carcinoma is divided into two types: a pure type and a composite type consisting of glandular and/or squamous differentiation [3]. The pure type was more common (60%) in previous reports [4][5][6].…”
Section: Discussionmentioning
confidence: 99%